Navigation Links
China Biologic Products Reports First Quarter 2008 Results
Date:5/15/2008

142,120

MINORITY INTEREST 4,110,623 3,885,892

SHAREHOLDERS' EQUITY:

Common stock, $0.0001 par value,

100,000,000 shares authorized,

21,434,942 shares issued and

outstanding at March 31, 2008

and December 31, 2007, respectively 2,143 2,143

Paid-in-capital 9,388,305 9,388,305

Statutory reserves 4,866,031 4,513,077

Retained earnings 7,798,152 5,883,306

Accumulated other comprehensive income 3,732,152 2,608,794

Total shareholders' equity 25,786,783 22,395,625

Total liabilities and

shareholders' equity $ 38,403,127 $ 33,305,245

CHINA BIOLOGIC PRODUCTS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME AND OTHER COMPREHENSIVE INCOME

FOR THE THREE MONTHS ENDED MARCH 31, 2008 AND 2007

(Unaudited)

2008 2007

REVENUES $ 7,849,007 $ 7,677,852

COST OF SALES 1,948,898 3,261,376

GROSS PROFIT 5,900,109 4,416,476

OPERATING EXPENSES

Selling expenses 494,529 497,613

General and administrative 1,584,128 938,598

expenses

Research and development expenses 183,782 149,907

TOTAL OPERATING EXPENSES 2,262,439 1,586,118

INCOME FROM OPERATIONS 3,637,670 2,830,358

OTHER EXPENSES

Finance expense 22,973 44,645

Othe
'/>"/>

SOURCE China Biologic Products, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... December 23, 2014 Earlier this year ... L. Sherley, director of the Adult Stem Cell Technology ... often overlooked and under appreciated unique property of adult ... Distributed Stem Cells: Misunderstood in the Past, Important for ... congress participants. He gave the address at the ...
(Date:12/24/2014)... December 23, 2014 The ... such as its definition, classification, application and ... specification, manufacturing process, and product cost structure. ... applications. The analysis also covers upstream raw ... industry development trend and proposals. In the ...
(Date:12/24/2014)... 23, 2014 China Biologic Products, Inc. ... leading fully integrated plasma-based biopharmaceutical company in ... majority-owned subsidiary, Shandong Taibang Biological Products Co. Ltd., ... the China Food and Drug Administration (the "CFDA") ... previously disclosed in the Company,s public filings, the ...
(Date:12/24/2014)... 2014  Rock Creek Pharmaceuticals, Inc., (NASDAQ: ... Clinical Trial Application (CTA) with the United ... seeking regulatory approval to initiate clinical trials for the ... Contingent on the Company receiving CTA regulatory approval, ... to assess the safety, tolerability and dose escalation of ...
Breaking Biology Technology:Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3
... New Best Practice Statements Were Presented at the ... YOKNEAM, Israel and PLYMOUTH MEETING, Pennsylvania, May 21 ... announced today that the,American Urological Association has introduced ... The guidelines state,that cryoablation is a treatment option ...
... Sweden, May 21 At the 14th ... 18-22, over 500 participants,including neurosurgeons, radiation oncologists ... for treatment of tumors and other,brain disorders ... in Quebec,Canada. During the meeting, 260 oral ...
... First Diagnostic Test Based on Company,s microRNA Technology Submitted for, Regulatory Approval to ... ... Validate and Offer Tests Based ... Two Additional microRNA-Related ...
Cached Biology Technology:American Urological Association (AUA) Clinical Guidelines Recognizes Cryotherapy as Treatment Option for Prostate Cancer Patients 2American Urological Association (AUA) Clinical Guidelines Recognizes Cryotherapy as Treatment Option for Prostate Cancer Patients 3Elekta Sees Record Attendance and Record Number of Submitted Abstracts at International Leksell Gamma Knife(R) Society Meeting in Quebec, Canada 2Elekta Sees Record Attendance and Record Number of Submitted Abstracts at International Leksell Gamma Knife(R) Society Meeting in Quebec, Canada 3Rosetta Genomics Reports First Quarter 2008 Financial Results 2Rosetta Genomics Reports First Quarter 2008 Financial Results 3Rosetta Genomics Reports First Quarter 2008 Financial Results 4Rosetta Genomics Reports First Quarter 2008 Financial Results 5Rosetta Genomics Reports First Quarter 2008 Financial Results 6Rosetta Genomics Reports First Quarter 2008 Financial Results 7Rosetta Genomics Reports First Quarter 2008 Financial Results 8Rosetta Genomics Reports First Quarter 2008 Financial Results 9Rosetta Genomics Reports First Quarter 2008 Financial Results 10
(Date:12/24/2014)... its launch in December 2014, the 1U™ ... pain of trying to remember their usernames and passwords ... fused to their smartphones. To assist people who have ... , the company that created 1U and focuses on ... app for free. 1U is an identity ...
(Date:12/22/2014)...  NXT-ID, Inc. (NASDAQ: NXTD and ... focused on the growing mobile commerce market, announces it ... Apollo Robbins for the 2015 International CES debut ... Apollo Robbins will be at the NXT-ID ... some of his famous theft techniques to visiting media ...
(Date:12/22/2014)... 22, 2014 Research and Markets ... addition of the "The Global Watermarking ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... overview of the global digital media watermarking ... and monitor piracy by securely and invisibly ...
Breaking Biology News(10 mins):1U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 4The Global Watermarking and Fingerprinting Markets 2
... the full text of the press releases and the ... note that all news releases are embargoed until Thursday, ... BREAST CANCER PATIENTS WHO WILL RESPOND TO CHEMOTHERAPY , ... genetic signature that can predict which breast cancer patients ...
... are characterized by poor vegetative cover, strong winds, ... this context, the land resources of Abu Dhabi ... to various land degradation stresses, including wind erosion, ... land resources of Abu Dhabi Emirate, land degradation ...
... in French . , Montreal, May 6, ... pregnancy, affecting more than 80 percent of future mothers. ... that hospitalization is required. Yet a new ... appears effective in improving symptoms more quickly and provides ...
Cached Biology News:IMPAKT -- Breast cancer conference highlights 2Wind, salt and water are leading indicators of land degradation in Abu Dhabi 2Treatment for extreme nausea, vomiting during pregnancy 2
Bis-Acrylamide (bis) is a monomer used as a crosslinker with acrylamide to form polyacrylamide electrophoretic gels. This 2% bis solution is supplied as 500 ml....
Anti-human VEGFR-2/KDR (Protein-A Purified) Polyclonal Antibody...
Mouse monoclonal antibody to Lats2....
Goat polyclonal to Lipocalin 2...
Biology Products: